Protagonist Therapeutics PTGX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's total equity?
- Protagonist Therapeutics (PTGX) reported total equity of $655.47M in Q1 2026.
- How has Protagonist Therapeutics's total equity changed year-over-year?
- Protagonist Therapeutics's total equity decreased by 4.9% year-over-year, from $689.05M to $655.47M.
- What is the long-term trend for Protagonist Therapeutics's total equity?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's total equity has grown at a 17.1% compound annual growth rate (CAGR), from $279.61M to $614.71M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.